Atabay Pharmaceutical
Atabay was founded in Istanbul by Mr. Ö. Kemalettin Atabay, Pharmacist, in 1939, prior to the outbreak of the Second World War. The company had emerged as a trading business, importing and marketing pharmaceutical products. In the 1940’s, this medium sized commercial operation developed into the production of sulfonamide tablets, which were in great demand at the time, thus paving the way to the pharmaceutical industry in Turkey.
tons of raw material production capacity
The sole manufacturer of
p-Aminophenol and Paracetamol in EMEA
+ API Development and Manufacturing
Pioneer in active pharmaceutical ingredient manufacturing — active substances for human, veterinary, and agrochemical applications
country raw material export reach
Exports to 67 Countries · 470 Licenses · 47 Distributors
+ employees
1,200+ employees across our overseas offices, Gebze facility, Acıbadem facility, and headquarters.
News & Announcements
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
A Groundbreaking Achievement from Atabay: 100% Domestic ‘From Seed to Shelf’ Herbal Medicine Production!
A Groundbreaking Achievement from Atabay: 100% Domestic 'From Seed to Shelf' Herbal Medicine Production! The pharmaceutical sector is one of a country's strategic domains. Approximately 90% of the medicines consumed in our country are domestically produced, while the...
Atabay BİO Türkiye’de aşı üretim iznine sahip GMP almış 5 tesisten biri
[vc_row][vc_column][dt_gallery_masonry mode="grid" responsiveness="post_width_based" pwb_column_min_width="600px" pwb_columns="0" image_border_radius="0px" project_icon_color="#ffffff" project_icon_border_width="0px"...
Turkey Pharmaceuticals & Biopharmaceuticals 2020
Global Business Report – Turkey Pharmaceuticals & Biopharmaceuticals 2020 https://www.gbreports.com/publication/turkey-pharmaceuticals-biopharmaceuticals-2020
GLOBAL BUSİNESS REPORT
Global Business Report - Zeynep Atabay Taskent & Dogan Taskent https://gbreports.com/interview/zeynep-atabay-taskent-dogan-taskent
Research and Development
Biotechnology & Vaccine
Atabay İlaç has completed the establishment of a facility to produce biosimilar drugs with the Biotechnology Group and continues its activities.
Effective Substance Synthesis
Atabay, which has a long history in pharmaceutical chemical synthesis, produces the active ingredients of very important human medicines in its facilities.
Sterile Production
Our facility has a production capacity of one million monthly and twelve million vials annually and has both aseptic filling and vial production capabilities.
OUR CERTIFICATES
